| Series Editors' foreword |
|
v | |
| Prefaces |
|
vi | |
| Acknowledgements |
|
viii | |
| Series Editors' acknowledgements |
|
ix | |
|
1 Principles of haematology |
|
|
1 | (10) |
|
|
|
1 | (1) |
|
|
|
1 | (1) |
|
|
|
1 | (1) |
|
|
|
2 | (3) |
|
|
|
5 | (1) |
|
|
|
6 | (2) |
|
|
|
8 | (3) |
|
2 Red blood cells and haemoglobin |
|
|
11 | (14) |
|
|
|
11 | (1) |
|
|
|
12 | (2) |
|
|
|
14 | (2) |
|
|
|
16 | (1) |
|
|
|
16 | (1) |
|
|
|
17 | (1) |
|
|
|
18 | (2) |
|
|
|
20 | (1) |
|
|
|
20 | (1) |
|
Full blood count and reticulocyte count |
|
|
21 | (1) |
|
|
|
22 | (3) |
|
3 Red blood cell disorders |
|
|
25 | (18) |
|
|
|
25 | (1) |
|
Anaemia secondary to haematinic deficiency |
|
|
26 | (4) |
|
Anaemia of chronic disease |
|
|
30 | (1) |
|
Anaemia due to blood loss |
|
|
30 | (1) |
|
Microcytic anaemia: other causes |
|
|
30 | (1) |
|
|
|
30 | (2) |
|
Antibody-mediated haemolysis |
|
|
32 | (1) |
|
Intrinsic red cell defects causing haemolysis |
|
|
33 | (1) |
|
Other causes of haemolysis |
|
|
34 | (2) |
|
|
|
36 | (4) |
|
Electrophoresis: investigation of haemoglobinopathies |
|
|
40 | (1) |
|
Marrow defects causing anaemia |
|
|
40 | (1) |
|
|
|
41 | (2) |
|
|
|
43 | (8) |
|
|
|
43 | (2) |
|
Leucocyte differentiation |
|
|
45 | (1) |
|
|
|
45 | (1) |
|
|
|
46 | (1) |
|
|
|
46 | (1) |
|
|
|
46 | (5) |
|
5 Haematological malignancies |
|
|
51 | (16) |
|
|
|
51 | (1) |
|
Myeloproliferative neoplasms |
|
|
51 | (2) |
|
Myelodysplastic syndromes |
|
|
53 | (1) |
|
|
|
54 | (1) |
|
|
|
55 | (2) |
|
|
|
57 | (1) |
|
|
|
58 | (3) |
|
Age-specific haematological malignancy risk |
|
|
61 | (1) |
|
|
|
61 | (2) |
|
Investigations in haematological malignancy |
|
|
63 | (2) |
|
Chemotherapy and targeted treatments |
|
|
65 | (2) |
|
|
|
67 | (22) |
|
|
|
67 | (1) |
|
|
|
67 | (2) |
|
|
|
69 | (1) |
|
|
|
70 | (3) |
|
|
|
73 | (1) |
|
|
|
73 | (3) |
|
Currently accepted pathway |
|
|
76 | (1) |
|
Regulation of coagulation |
|
|
76 | (1) |
|
|
|
77 | (1) |
|
|
|
77 | (1) |
|
|
|
77 | (2) |
|
Clotting factor disorders |
|
|
79 | (1) |
|
Hereditary factor deficiencies |
|
|
80 | (2) |
|
|
|
82 | (1) |
|
Secondary (acquired) thrombophilias |
|
|
82 | (1) |
|
Primary (hereditary) thrombophilias |
|
|
83 | (1) |
|
|
|
83 | (1) |
|
|
|
84 | (2) |
|
|
|
86 | (1) |
|
|
|
86 | (3) |
|
|
|
89 | (16) |
|
|
|
89 | (2) |
|
|
|
91 | (1) |
|
|
|
91 | (2) |
|
The Rh antigen (previously termed `rhesus antigen') system |
|
|
93 | (1) |
|
|
|
94 | (1) |
|
|
|
94 | (2) |
|
Alternatives to red cell transfusions |
|
|
96 | (1) |
|
Other transfusion products |
|
|
97 | (2) |
|
Transfusion complications |
|
|
99 | (2) |
|
|
|
101 | (4) |
|
8 Principles of immunology |
|
|
105 | (2) |
|
An introduction to immunology |
|
|
105 | (2) |
|
9 The innate immune system |
|
|
107 | (10) |
|
|
|
107 | (1) |
|
|
|
107 | (3) |
|
|
|
110 | (4) |
|
Innate immune system pattern recognition molecules |
|
|
114 | (3) |
|
10 The adaptive immune system |
|
|
117 | (16) |
|
The immunoglobulin domain |
|
|
117 | (4) |
|
Generation of antigen receptor diversity |
|
|
121 | (2) |
|
|
|
123 | (4) |
|
|
|
127 | (4) |
|
|
|
131 | (2) |
|
11 The functioning immune system |
|
|
133 | (10) |
|
Response to tissue damage |
|
|
133 | (3) |
|
Immune response to pathogens |
|
|
136 | (7) |
|
|
|
143 | (18) |
|
|
|
143 | (1) |
|
Type I hypersensitivity (immediate hypersensitivity) |
|
|
143 | (3) |
|
|
|
146 | (1) |
|
Type III hypersensitivity (immune complex) |
|
|
147 | (1) |
|
Type IV hypersensitivity (delayed-type hypersensitivity) |
|
|
148 | (3) |
|
Development of hypersensitivity |
|
|
151 | (2) |
|
|
|
153 | (5) |
|
Investigation of immune function |
|
|
158 | (3) |
|
|
|
161 | (8) |
|
|
|
161 | (2) |
|
|
|
163 | (1) |
|
|
|
164 | (3) |
|
|
|
167 | (2) |
| Self-Assessment |
|
169 | (2) |
| Single best answer (SBA) questions |
|
171 | (12) |
| Extended-matching questions (EMQs) |
|
183 | (8) |
| SBA answers |
|
191 | (10) |
| EMQ answers |
|
201 | (6) |
| Glossary |
|
207 | (2) |
| Index |
|
209 | |
